Investigation of the Montreal Cognitive Assessment (MoCA) as a cognitive screener in severe mental illness

Psychiatry Research

Volumn 220, Issue 1-2, 2014, Pages 664-668

  Musso, Mandi W ^a   Cohen, Alex S ^a   Auster, Tracey L ^a   McGovern, Jessica E ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Bipolar disorder; Cognitive deficits; Depression; Functional outcomes; Neuropsychology; Schizophrenia

Indexed keywords

PSYCHOTROPIC AGENT;

ADULT; ARTICLE; BRIEF ASSESSMENT OF COGNITION IN SCHIZOPHRENIA; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; COGNITIVE DEFECT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; EXPERIMENTAL STUDY; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; FUNCTIONAL STATUS; GLOBAL ASSESSMENT OF FUNCTIONING; HUMAN; MALE; MENTAL DISEASE; MONTREAL COGNITIVE ASSESSMENT; OUTPATIENT; PSYCHOMETRY; REFERENCE VALUE; SCORING SYSTEM; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; UCSD PERFORMANCE BASED SKILLS ASSESSMENT TEST 2; COGNITION; COGNITION DISORDERS; EVALUATION STUDY; MIDDLE AGED; MOOD DISORDER; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX;

ADULT; COGNITION; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOOD DISORDERS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; SCHIZOPHRENIC PSYCHOLOGY; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 84908231290     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2014.07.078     Document Type: Article

References (28)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Association, Washington, DC, (text rev. Author). 4th ed.
2. First M., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV) 1996, American Psychiatric Press, Washington, DC.
3. First M., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition. (SCID-I/NP). Biometrics Research 2002, New York State Psychiatric Institute, New York.
4. Fisekovic S., Memic A., Burnazovic-Ristic L. Evaluation of the effectiveness of treatment response applying PANSS, GAF and MoCA in patients with schizophrenia. Folia Medica Facultatis Medicinae Universitatis Saraeviensis 2012, 47(1):54-61.
5. Fisekovic S., Memic A., Pasalic.A. Correlation between MoCA and MMSE for the assessment of cognition in schizophrenia. Acta Informatica Medica 2012, 20(3):186-189.
6. Ganjuli R., Brar J.S., Vemulapalli H., Jafar H., Ahuja R., Sharma S., Wirth R.J. Mini-Mental State Examination (MMSE) performance of partially remitted community-dwelling patients with schizophrenia. Schizophrenia Research 1998, 33(1-2):45-52.
7. Goldberg T.E., Green M.F. Neurocognitive functioning in patients with schizophrenia: an overview. Neuropsychopharmacology: The Fifth Generation of Progress 2002, 657-670. Lippincott Williams & Wilkins, Philadelphia. K.L. Davis, D. Charney, J.T. Coyle, C. Nemeroff (Eds.).
8. Green M.F. What are the functional consequences of neurocognitive deficits in schizophrenia?. American Journal of Psychiatry 1996, 153(3):321-330.
9. Green M.F., Nuechterlein K.H. Should schizophrenia be treated as a neurocognitive disorder?. Schizophrenia Bulletin 1999, 25(2):309-319.
10. Green M.F., Nuechterlein K.H., Gold J.M., Barch D.M., Cohen J., Essock S., Fenton W.S., Frese F., Goldberg T.E., Heaton R.K., Keefe R.S.E., Kern R.S., Kraemer H., Stover E., Weinberger D.R., Zalcman S., Marder S.R. Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biological Psychiatry 2004, 56(5):301-307.
11. Harvey P.D., Green M.F., Nuechterlein K.H. Latest developments in the MATRICS process. Psychiatry 2010, 7(6):49-52.
12. Heinrichs R.W., Zakzanis K.K. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 1998, 12(3):426-445.
13. Keefe R.S.E., Goldberg T.E., Harvey P.D., Gold J.M., Poe M., Coughenour L. The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophrenia Research 2004, 68(2-3):283-297.
14. Keefe R.S.E., Poe M., Walker T.M., Harvey P.D. The relationship of the Brief Assesment of Cognition in Schizophrenia (BACS) to functional capacity and real-world functional outcome. Journal of Clinical and Experimental Neuropsychology 2006, 28(2):260-269.
15. Kurtz M.M., Gerraty R.T. A meta-analytic investigation of neurocognitive deficits in bipolar illness. Neuropsychology 2009, 23(5):551-562.
16. Larner A.J. Screening utility of the Montreal Cognitive Assessment (MoCA): in place of-or as well as-the MMSE?. International Psychogeriatrics 2012, 24(3):391-396.
17. Lawton M.P., Brody E.M. Assessment of older people: self-maintaining and instrumental activities of daily living. The Gerontologist 1969, 9(3):179-186.
18. Manning V., Wanigaratne S., Best D., Strathdee G., Schrover I., Gossop M. Screening for cognitive functioning in psychiatric outpatients with schizophrenia, alcohol dependence, and dual diagnosis. Schizophrenia Research 2007, 91(1):151-158.
19. McCall W.V., Dunn A.G. Cognitive deficits are associated with functional impairment in severely depressed patients. Psychiatry Research 2003, 121(2):179-184.
20. McDermott L.M., Ebmeier K.P. A meta-analysis of depression severity and cognitive function. Journal of Affective Disorders 2009, 119(1-3):1-8.
21. Moore D.J., Palmer B.W., Jeste D.V. Use of the mini-mental state exam in middle-aged and older outpatients with schizophrenia: cognitive impairment and its associations. The American Journal of Geriatric Psychiatry 2004, 12(4):412-419.
22. Nasreddine Z.S., Phillips N.A., Bédirian V., Charbonneau S., Whitehead V., Collin I., Cummings J.L., Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of American Geriatrics Society 2005, 53(4):695-699.
23. Nuechterlein K.H., Dawson M.E., Green M.F. Information-processing abnormalities as neuropsychological vulnerability indicators for schizophrenia. Acta Psychiatrica Scandinavica 1994, 90(Suppl. 384):S71-S79.
24. Robinson L.J., Thompson J.M., Gallagher P., Goswami U., Young A.H., Ferrier I.N., Moore P.B. A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. Journal of Affective Disorders 2006, 93(1-3):105-115.
25. Rossetti H.C., Lacritz L.H., Cullum M. Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample. Neurology 2011, 77:1272-1275.
26. Versterager L., Christensen T.Ø., Olsen B.B., Krarup G., Melau M., Forchhammer H.B., Nordentoft M. Cognitive and clinical predictors of functional capacity in patients with first episode schizophrenia. Schizophrenia Research 2012, 141(2-3):251-256.
27. Wingo A.P., Harvey P.D., Baldessarini R.J. Neurocognitive impairment in bipolar disorder patients: functional implications. Bipolar Disorders 2009, 11(2):113-125.
28. Withall A., Harris L.M., Cumming S.R. The relationship between cognitive function and clinical and functional outcomes in major depressive disorder. Psychological Medicine 2009, 39(3):393-402.